NEOMYCIN AND POLYMY
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS Pharmaceutical Group Inc. under contract SPE2DP25F7398 for the delivery of NEOMYCIN AND POLYMY, identified by NSN 6505010430230, as part of a delivery order linked to the basic contract SPE2DX15D9383. The award was issued on July 30, 2026, and the total contract value is specified in the award documentation, though the exact amount is not provided here. The procurement is classified as a federal acquisition with no set-aside designation, and the contract is managed by the Department of Defense through the DLA. Performance is expected to align with federal supply standards, with no specific delivery location detailed in the metadata. The contract is accessible through the DIBBS portal using the provided UI link for additional terms and condition details.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
